SANDOSTATINE sol inj 0.05 mg/ml 5 amp 1 ml
7680491370283
CH-49137
H01CB02
07.16.2.
Reimbursement limitations:
SANDOSTATIN
Tumeurs du système endocrine gastroentéropancréatique.
Acromégalie qui ne réagit pas ou pas suffisamment à d'autres …
1 / 2
google
Details
- Product number
- 4913701
- CPT
- -
- Packaging group
- 5 x 1 ml
- Unit
- Ampulle(n)
- Composition
- octreotidum 0.05 mg ut octreotidi acetas, mannitolum, acidum lacticum, natrii hydrogenocarbonas q.s. ad pH, aqua ad iniectabile ad solutionem pro 1 ml.
Articles (1)
Sandostatin 0,05 mg/mL, Injektionslösung
Injektionslösung
5 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.05 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 40.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1989
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 49137
- Drug name
- Sandostatin, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- H01CB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/08/1988
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SANDOSTATINE sol inj 0.05 mg/ml 5 amp 1 ml
- Description (DE)
- SANDOSTATIN Inj Lös 0.05 mg/ml 5 Amp 1 ml
- Market launch
- 15/08/1988
- Narcotic (BTM)
- No